Abstract:Background & Aims: Although CD8(+)T cell exhaustion hampers viral control during chronic HBV infection, the pool of CD8(+)T cells is phenotypically and functionally heterogeneous. Therefore, a specific subpopulation of CD8(+)T cells should be further investigated. This study aims to dissect a subset of CD8(+)T cells expressing C-X-C motif chemokine receptor 5 (CXCR5) in chronic HBV infection. Methods: The frequency of CXCR5(+)CD8(+)T cells and the levels of C-X-C motif chemokine ligand 13 (CXCL13), a chemokine of CXCR5, were measured in patients with chronic HBV infection. C57BL/6, interleukin (IL)-21 receptor- or B cell-deficient mice were hydrodynamically injected with pAAV-HBV1.2 plasmids. Phenotype and functions of peripheral and intrahepatic CXCR5(+) and CXCR5(-)CD8(+)T cells were assessed. Results: CXCR5(+)CD8(+)T cells were partially exhausted but possessed a stronger antiviral ability than the CXCR5(-) subset in patients with chronic HBV infection; moreover, CXCR5(+)CD8(+)T cells were associated with a favorable treatment response in patients with chronic hepatitis B (CHB). High levels of CXCL13 from patients with CHB facilitated the recruitment of intrahepatic CXCR5(+)CD8(+)T cells, and this subpopulation produced high levels of HBV-specific interferon (IFN)-gamma and IL-21. Notably, PD1 (programmed death 1) blockade and exogenous IL-21 enhanced the production of IFN-gamma. More strikingly, mice injected with CXCR5(+)CD8(+)T cells showed remarkably decreased expression of HBsAg. Additionally, an impaired production of HBV-specific IFN-gamma from intrahepatic CXCR5(+)CD8(+)T cells was observed in IL-21 receptor- or B cell-deficient mice. Conclusion: CXCL13 promotes the recruitment of CXCR5(+)CD8(+)T cells to the liver, and this subpopulation improves viral control in chronic HBV infection. The identification of this unique sub- population may contribute to a better understanding of CD8(+)T cell functions and provide a potential immunotherapeutic target in chronic HBV infection. Lay summary: Exhaustion of CD8(+)T cells is an important factor in the development of chronic hepatitis B virus (HBV) infection. CD8(+)T cells expressing the receptor CXCR5 are partially exhausted, but have potent antiviral activity, as they produce high levels of HBV-specific cytokines in chronic HBV infection. Increased expression of CXCL13 within the liver facilitates the recruitment of CXCR5(+)CD8(+)T cells and establishes effective immune control of HBV infection. (C) 2019 European Association for the Study of the Liver. Published by Elsevier B.V.

Hepatocyte-Derived L-Carnitine Restricts Hepatitis B Surface Antigen Loss Through an Immunosuppressive Effect on Germinal Center-Related Immune Cells

High L-Carnitine Levels Impede Viral Control in Chronic Hepatitis B Virus Infection

Increasing LAG-3 Expression Suppresses T-cell Function in Chronic Hepatitis B

Increasing LAG-3 expression suppresses T-cell function in chronic hepatitis B: A balance between immunity strength and liver injury extent.

CXCL13-mediated Recruitment of Intrahepatic CXCR5+CD8+T Cells Favors Viral Control in Chronic HBV Infection.

Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection

Metabolic Regulation of Hepatitis B Immunopathology by Myeloid-Derived Suppressor Cells

HBsAg Stimulates NKG2D Receptor Expression on Natural Killer Cells and Inhibits Hepatitis C Virus Replication

Lymphocyte Activation Gene 3 Negatively Regulates the Function of Intrahepatic Hepatitis C Virus‐specific CD8+ T Cells

Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients

Immunomodulatory and Antiviral Therapy Improved Functional Cure Rate in CHB Patients with High HBsAg Level Experienced NA.

Down-regulation of Cell Membrane Localized NTCP Expression in Proliferating Hepatocytes Prevents Hepatitis B Virus Infection.

Effects of Regulatory T Cells on Anti-Viral Immune Responses Impaired by Chronic Hepatitis B

Hepatic T Cell Suppressors and Their Inhibition Roles in Hepatic Viral Clearance (P6353)

Nanoparticles Encapsulating Hepatitis B Virus Cytosine-Phosphate-guanosine Induce Therapeutic Immunity Against HBV Infection.

Inhibitory Effect of Cyclosporine A on Hepatitis B Virus Replication in Vitro and Its Possible Mechanisms.

Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice

Chimeric Antigen Receptors of HBV Envelope Proteins Inhibit Hepatitis B Surface Antigen Secretion.

Antiviral therapy reduces hepatocellular carcinoma through suppressing hepatitis B virus replication may improve ER stress, mitochondrial and metabolic dysfunctions and decrease p62 in hybridized mice with single HBV transgene and miR‐122

Inhibition of CD4+ CD25+ Regulatory T Cells in Chronic Hepatitis B Patients

Hepatocellular carcinoma reduced, HBsAg loss increased and survival improved after finite therapy in hepatitis B patients with cirrhosis